Broadfin Capital’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Broadfin Capital’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,000	Closed	-$5.34M	–	83
2016 Q1	$5.34M	Buy	+100,000	New	+$7.38M	0.52%	47
2015 Q2	–	Sell	-184,320	Closed	-$10.7M	–	103
2015 Q1	$10.7M	Sell	184,320 -320,000	-63%	-$13.6M	0.83%	36
2014 Q4	$16.3M	Sell	504,320 -276,500	-35%	-$8.3M	1.41%	21
2014 Q3	$19.1M	Sell	780,820 -662,400	-46%	-$13.5M	2%	15
2014 Q2	$25.6M	Buy	1,443,220 +442,351	+44%	+$7.12M	2.5%	12
2014 Q1	$20M	Sell	1,000,869 -516,362	-34%	-$10M	1.94%	16
2013 Q4	$25.5M	Sell	1,517,231 -220,438	-13%	-$3.05M	3.36%	9
2013 Q3	$18.5M	Buy	1,737,669 +13,641	+0.8%	+$119K	3.28%	11
2013 Q2	$9.64M	Buy	+1,724,028	New	+$10.4M	1.89%	19

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Broadfin Capital's ANAC Position: Q2 2016 in Review

Broadfin Capital sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 100,000 shares — an estimated $5.34M sold.

Broadfin Capital first reported a position in ANAC in Q2 2013 and held it in 9 quarters. The position peaked at $25.6M in Q2 2014. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Broadfin Capital reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Broadfin Capital sold 100,000 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.34M.
Broadfin Capital first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 9 quarters.
Broadfin Capital's ANACOR PHARMACEUTICALS INC COM position peaked at $25.6M in Q2 2014.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Broadfin Capital's 13F filing for Q2 2016, filed 15 Aug 2016.